Contraceptives-United States Market Status and Trend Report 2013-2023
Report Summary
Contraceptives-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Contraceptives industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Contraceptives 2013-2017, and development forecast 2018-2023
Main market players of Contraceptives in United States, with company and product introduction, position in the Contraceptives market
Market status and development trend of Contraceptives by types and applications
Cost and profit status of Contraceptives, and marketing status
Market growth drivers and challenges
The report segments the United States Contraceptives market as:
United States Contraceptives Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023)
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Contraceptives Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Oral Contraceptive Pills
Injectables
Topical
United States Contraceptives Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Male
Female
United States Contraceptives Market: Players Segment Analysis (Company and Product introduction, Contraceptives Sales Volume, Revenue, Price and Gross Margin):
The Female Health Company
Teva Pharmaceutical
Reckitt Benckiser
Pfizer
Mayer Laboratories
Cooper Surgical
Church & Dwight
Actavis
Merck & Co.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Contraceptives-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Contraceptives industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Contraceptives 2013-2017, and development forecast 2018-2023
Main market players of Contraceptives in United States, with company and product introduction, position in the Contraceptives market
Market status and development trend of Contraceptives by types and applications
Cost and profit status of Contraceptives, and marketing status
Market growth drivers and challenges
The report segments the United States Contraceptives market as:
United States Contraceptives Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023)
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Contraceptives Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Oral Contraceptive Pills
Injectables
Topical
United States Contraceptives Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Male
Female
United States Contraceptives Market: Players Segment Analysis (Company and Product introduction, Contraceptives Sales Volume, Revenue, Price and Gross Margin):
The Female Health Company
Teva Pharmaceutical
Reckitt Benckiser
Pfizer
Mayer Laboratories
Cooper Surgical
Church & Dwight
Actavis
Merck & Co.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF CONTRACEPTIVES
1.1 Definition of Contraceptives in This Report
1.2 Commercial Types of Contraceptives
1.2.1 Oral Contraceptive Pills
1.2.2 Injectables
1.2.3 Topical
1.3 Downstream Application of Contraceptives
1.3.1 Male
1.3.2 Female
1.4 Development History of Contraceptives
1.5 Market Status and Trend of Contraceptives 2013-2023
1.5.1 United States Contraceptives Market Status and Trend 2013-2023
1.5.2 Regional Contraceptives Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Contraceptives in United States 2013-2017
2.2 Consumption Market of Contraceptives in United States by Regions
2.2.1 Consumption Volume of Contraceptives in United States by Regions
2.2.2 Revenue of Contraceptives in United States by Regions
2.3 Market Analysis of Contraceptives in United States by Regions
2.3.1 Market Analysis of Contraceptives in New England 2013-2017
2.3.2 Market Analysis of Contraceptives in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Contraceptives in The Midwest 2013-2017
2.3.4 Market Analysis of Contraceptives in The West 2013-2017
2.3.5 Market Analysis of Contraceptives in The South 2013-2017
2.3.6 Market Analysis of Contraceptives in Southwest 2013-2017
2.4 Market Development Forecast of Contraceptives in United States 2018-2023
2.4.1 Market Development Forecast of Contraceptives in United States 2018-2023
2.4.2 Market Development Forecast of Contraceptives by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Contraceptives in United States by Types
3.1.2 Revenue of Contraceptives in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Contraceptives in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Contraceptives in United States by Downstream Industry
4.2 Demand Volume of Contraceptives by Downstream Industry in Major Countries
4.2.1 Demand Volume of Contraceptives by Downstream Industry in New England
4.2.2 Demand Volume of Contraceptives by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Contraceptives by Downstream Industry in The Midwest
4.2.4 Demand Volume of Contraceptives by Downstream Industry in The West
4.2.5 Demand Volume of Contraceptives by Downstream Industry in The South
4.2.6 Demand Volume of Contraceptives by Downstream Industry in Southwest
4.3 Market Forecast of Contraceptives in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CONTRACEPTIVES
5.1 United States Economy Situation and Trend Overview
5.2 Contraceptives Downstream Industry Situation and Trend Overview
CHAPTER 6 CONTRACEPTIVES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Contraceptives in United States by Major Players
6.2 Revenue of Contraceptives in United States by Major Players
6.3 Basic Information of Contraceptives by Major Players
6.3.1 Headquarters Location and Established Time of Contraceptives Major Players
6.3.2 Employees and Revenue Level of Contraceptives Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 CONTRACEPTIVES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 The Female Health Company
7.1.1 Company profile
7.1.2 Representative Contraceptives Product
7.1.3 Contraceptives Sales, Revenue, Price and Gross Margin of The Female Health Company
7.2 Teva Pharmaceutical
7.2.1 Company profile
7.2.2 Representative Contraceptives Product
7.2.3 Contraceptives Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
7.3 Reckitt Benckiser
7.3.1 Company profile
7.3.2 Representative Contraceptives Product
7.3.3 Contraceptives Sales, Revenue, Price and Gross Margin of Reckitt Benckiser
7.4 Pfizer
7.4.1 Company profile
7.4.2 Representative Contraceptives Product
7.4.3 Contraceptives Sales, Revenue, Price and Gross Margin of Pfizer
7.5 Mayer Laboratories
7.5.1 Company profile
7.5.2 Representative Contraceptives Product
7.5.3 Contraceptives Sales, Revenue, Price and Gross Margin of Mayer Laboratories
7.6 Cooper Surgical
7.6.1 Company profile
7.6.2 Representative Contraceptives Product
7.6.3 Contraceptives Sales, Revenue, Price and Gross Margin of Cooper Surgical
7.7 Church & Dwight
7.7.1 Company profile
7.7.2 Representative Contraceptives Product
7.7.3 Contraceptives Sales, Revenue, Price and Gross Margin of Church & Dwight
7.8 Actavis
7.8.1 Company profile
7.8.2 Representative Contraceptives Product
7.8.3 Contraceptives Sales, Revenue, Price and Gross Margin of Actavis
7.9 Merck & Co.
7.9.1 Company profile
7.9.2 Representative Contraceptives Product
7.9.3 Contraceptives Sales, Revenue, Price and Gross Margin of Merck & Co.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CONTRACEPTIVES
8.1 Industry Chain of Contraceptives
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CONTRACEPTIVES
9.1 Cost Structure Analysis of Contraceptives
9.2 Raw Materials Cost Analysis of Contraceptives
9.3 Labor Cost Analysis of Contraceptives
9.4 Manufacturing Expenses Analysis of Contraceptives
CHAPTER 10 MARKETING STATUS ANALYSIS OF CONTRACEPTIVES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Contraceptives in This Report
1.2 Commercial Types of Contraceptives
1.2.1 Oral Contraceptive Pills
1.2.2 Injectables
1.2.3 Topical
1.3 Downstream Application of Contraceptives
1.3.1 Male
1.3.2 Female
1.4 Development History of Contraceptives
1.5 Market Status and Trend of Contraceptives 2013-2023
1.5.1 United States Contraceptives Market Status and Trend 2013-2023
1.5.2 Regional Contraceptives Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Contraceptives in United States 2013-2017
2.2 Consumption Market of Contraceptives in United States by Regions
2.2.1 Consumption Volume of Contraceptives in United States by Regions
2.2.2 Revenue of Contraceptives in United States by Regions
2.3 Market Analysis of Contraceptives in United States by Regions
2.3.1 Market Analysis of Contraceptives in New England 2013-2017
2.3.2 Market Analysis of Contraceptives in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Contraceptives in The Midwest 2013-2017
2.3.4 Market Analysis of Contraceptives in The West 2013-2017
2.3.5 Market Analysis of Contraceptives in The South 2013-2017
2.3.6 Market Analysis of Contraceptives in Southwest 2013-2017
2.4 Market Development Forecast of Contraceptives in United States 2018-2023
2.4.1 Market Development Forecast of Contraceptives in United States 2018-2023
2.4.2 Market Development Forecast of Contraceptives by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Contraceptives in United States by Types
3.1.2 Revenue of Contraceptives in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Contraceptives in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Contraceptives in United States by Downstream Industry
4.2 Demand Volume of Contraceptives by Downstream Industry in Major Countries
4.2.1 Demand Volume of Contraceptives by Downstream Industry in New England
4.2.2 Demand Volume of Contraceptives by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Contraceptives by Downstream Industry in The Midwest
4.2.4 Demand Volume of Contraceptives by Downstream Industry in The West
4.2.5 Demand Volume of Contraceptives by Downstream Industry in The South
4.2.6 Demand Volume of Contraceptives by Downstream Industry in Southwest
4.3 Market Forecast of Contraceptives in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CONTRACEPTIVES
5.1 United States Economy Situation and Trend Overview
5.2 Contraceptives Downstream Industry Situation and Trend Overview
CHAPTER 6 CONTRACEPTIVES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Contraceptives in United States by Major Players
6.2 Revenue of Contraceptives in United States by Major Players
6.3 Basic Information of Contraceptives by Major Players
6.3.1 Headquarters Location and Established Time of Contraceptives Major Players
6.3.2 Employees and Revenue Level of Contraceptives Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 CONTRACEPTIVES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 The Female Health Company
7.1.1 Company profile
7.1.2 Representative Contraceptives Product
7.1.3 Contraceptives Sales, Revenue, Price and Gross Margin of The Female Health Company
7.2 Teva Pharmaceutical
7.2.1 Company profile
7.2.2 Representative Contraceptives Product
7.2.3 Contraceptives Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
7.3 Reckitt Benckiser
7.3.1 Company profile
7.3.2 Representative Contraceptives Product
7.3.3 Contraceptives Sales, Revenue, Price and Gross Margin of Reckitt Benckiser
7.4 Pfizer
7.4.1 Company profile
7.4.2 Representative Contraceptives Product
7.4.3 Contraceptives Sales, Revenue, Price and Gross Margin of Pfizer
7.5 Mayer Laboratories
7.5.1 Company profile
7.5.2 Representative Contraceptives Product
7.5.3 Contraceptives Sales, Revenue, Price and Gross Margin of Mayer Laboratories
7.6 Cooper Surgical
7.6.1 Company profile
7.6.2 Representative Contraceptives Product
7.6.3 Contraceptives Sales, Revenue, Price and Gross Margin of Cooper Surgical
7.7 Church & Dwight
7.7.1 Company profile
7.7.2 Representative Contraceptives Product
7.7.3 Contraceptives Sales, Revenue, Price and Gross Margin of Church & Dwight
7.8 Actavis
7.8.1 Company profile
7.8.2 Representative Contraceptives Product
7.8.3 Contraceptives Sales, Revenue, Price and Gross Margin of Actavis
7.9 Merck & Co.
7.9.1 Company profile
7.9.2 Representative Contraceptives Product
7.9.3 Contraceptives Sales, Revenue, Price and Gross Margin of Merck & Co.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CONTRACEPTIVES
8.1 Industry Chain of Contraceptives
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CONTRACEPTIVES
9.1 Cost Structure Analysis of Contraceptives
9.2 Raw Materials Cost Analysis of Contraceptives
9.3 Labor Cost Analysis of Contraceptives
9.4 Manufacturing Expenses Analysis of Contraceptives
CHAPTER 10 MARKETING STATUS ANALYSIS OF CONTRACEPTIVES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
